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Annually 4.5 million platelet units are transfused in Europe and the United States. These are obtained solely 
from allogeneic donations and have a shelf life of 5-7 days. To address the corresponding supply challenge, 
Moreau et al.1 devised a novel process for producing megakaryocytes (MKs, the platelet precursor cell) in vitro. 
A transcription-factor driven, forward-programming (FOP) approach converts human pluripotent stem cells into 
MKs. This strategy has the unique advantage of generating high yields of pure MKs in chemically defined 
medium which could lead to the production of a consistent, reliable supply of platelets which overcomes the 
logistical, financial and biosafety challenges for health organisations worldwide.  
 
Here we follow a Quality by Design (QbD) approach to enable improvements to the upstream processing of 
FOPMKs. Firstly, we created a process flow diagram for production of in vitro platelets for transfusion, which 
segregated processes into individual unit operations for control and optimisation. Next, we developed a Quality 
Target Product Profile (QTPP) and identified Critical Quality Attributes (CQAs) for each stage.  
 
We conducted a range of experiments utilising Design of Experiments (DOE) and mechanistic modelling2 tools 
to link Critical Process Parameters (CPPs) to CQAs. For adherent culture, we identified a productivity limit 
related to surface area available for growth and a cell loss phase which was dependent on cell seeding density, 
RhoK inhibitor usage and seed density. Using suspension cultures of FOPMK. We noted that TPO and 
Doxycycline concentration were CPPs as these impacted cell net growth rate and phenotype trajectory. 
Furthermore, we noted that medium exhaustion led to a 30% loss of viable cells over 8 hours. Proof of concept 
studies also showed that FOPMKs can be cultured in scaled-down suspension systems (ambr-15 and spinner 
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